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Abstract
Background: Metabolic syndrome, a constellation of metabolic risk factors for type 2 diabetes and cardiovascular
disease, is one of the fastest growing disease entities in the world. Weight loss is thought to be a key to improving
all aspects of metabolic syndrome. Research studies have suggested benefits from diets rich in vegetables and
fruits in helping individuals reach and achieve healthy weights.
Objective: To evaluate the effects of a ready to serve vegetable juice as part of a calorie-appropriate Dietary
Approaches to Stop Hypertension (DASH) diet in an ethnically diverse population of people with Metabolic
Syndrome on weight loss and their ability to meet vegetable intake recommendations, and on their clinical
characteristics of metabolic syndrome (waist circumference, triglycerides, HDL, fasting blood glucose and blood
pressure).
A secondary goal was to examine the impact of the vegetable juice on associated parameters, including leptin,
vascular adhesion markers, and markers of the oxidative defense system and of oxidative stress.
Methods: A prospective 12 week, 3 group (0, 8, or 16 fluid ounces of low sodium vegetable juice) parallel arm
randomized controlled trial. Participants were requested to limit their calorie intake to 1600 kcals for women and
1800 kcals for men and were educated on the DASH diet. A total of 81 (22 men & 59 women) participants with
Metabolic Syndrome were enrolled into the study. Dietary nutrient and vegetable intake, weight, height, leptin,
metabolic syndrome clinical characteristics and related markers of endothelial and cardiovascular health were
measured at baseline, 6-, and 12-weeks.
Results: There were significant group by time interactions when aggregating both groups consuming vegetable
juice (8 or 16 fluid ounces daily). Those consuming juice lost more weight, consumed more Vitamin C, potassium,
and dietary vegetables than individuals who were in the group that only received diet counseling (p < 0.05).
Conclusion: The incorporation of vegetable juice into the daily diet can be a simple and effective way to increase
the number of daily vegetable servings. Data from this study also suggest the potential of using a low sodium
vegetable juice in conjunction with a calorie restricted diet to aid in weight loss in overweight individuals with
metabolic syndrome.
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Metabolic syndrome, a constellation of metabolic risk
factors for type 2 diabetes and cardiovascular disease, is
one of the fastest growing disease entities in the world
[1,2]; as an example in the United States it is thought to
affect over 30% of adults [3]. Weight loss is thought to
be a key to improving all aspects of metabolic syndrome
[4]. Research studies have suggested a number of bene-
fits of diets rich in vegetables and fruits in helping indi-
viduals reach and achieve healthy weights [5].
Vegetables and fruits, which are typically low in calories,
can provide an abundance of essential nutrients and
health promoting phytochemicals [6]. Clinical science
and public health data underscore the potential health
benefits that could be realized if vegetable intakes
matched current dietary recommendations [7]. Regretta-
bly, adopting and maintaining a healthy lifestyle, includ-
ing a diet rich in vegetables, fruits, lean meats and low
fat dairy products, seems to be problematic for many
individuals, even when they are aware of its benefits [8].
For example, McGee et al. reported that focus group
participants from the Lower Mississippi Delta with
chronic disease risk factors resisted adopting a healthy
diet, when it meant giving up traditional or culture-
related dietary habits [9]. Data show that older ethnic
minorities do not meet the minimum recommendations
for vegetables and fruits [10]. Preparation time [9], price
[11], taste [12], and lack of convenience [13] are among
barriers that have been reported to contribute to the
low consumption of vegetables and fruits.
Research on the favorable effects of vegetables and
fruits and their phytochemicals is expanding rapidly
with data showing positive impacts of many plant foods
on risk factors for chronic diseases [14]. Specific to
metabolic syndrome, diets high in vegetables have been
reported to have beneficial effects with respect to fasting
blood glucose, dyslipidemia, and hypertension [15-18].
While it could be argued that the above positive effects
of high vegetable diets may simply reflect the adoption
of “healthy diets,” there is increasing evidence that some
of the reported positive effects may be linked to specific
phytochemicals. For example, it has been reported that
carotenoids can inhibit damage and thickening of the
arterial wall, possibly due to their ability to lower the
production of select inflammatory cytokines [19]. Simi-
larly, data with an inverse association of plasma lyco-
pene levels and intima thickening, one index of
cardiovascular disease [20] has been reported. Two dif-
ferent double-blind, placebo-controlled trials, showed a
tomato extract significantly reduced systolic and diasto-
lic blood pressure; one study had patients with grade 1
hypertension [21], and another with moderate hyperten-
sion despite anti-hyptertensive medication at enrollment
[22]. In another study, beneficial results on platelet
function were reported in healthy volunteers after drink-
ing a tomato extract [23,24]. Research is increasing not
only on the individual phytochemicals, but also on their
potential synergistic health benefits [25].
The primary goal of the present research was to
examine the effects of consuming 8 or 16 fluid ounces
of low sodium vegetable juice as part of a calorie-appro-
priate Dietary Approaches to Stop Hypertension
(DASH) diet in an ethnically diverse population on the
ability of vegetable juice to help subjects lose weight,
meet their recommended vegetable intake, and on clini-
cal characteristics of metabolic syndrome (waist circum-
ference, triglycerides, HDL, fasting blood glucose and
blood pressure). A secondary goal was to examine the
impact of the incorporation of vegetable juice in the diet
on associated parameters, including leptin, vascular
adhesion markers, and markers of the oxidative defense
system and oxidative stress.
Methods
Study Population and Setting
Adult men and women, ages 35-65, were recruited from
the Houston, TX community using advertisements
placed on several key radio stations, in local neighbor-
hood and business newspapers, free newspapers contain-
ing advertising, and the Baylor College of Medicine
health newsletter. Two hundred and fifty-three indivi-
duals were screened in the clinic and 81 (59 women and
22 men) met inclusionary criteria and were randomized
into the study. Those who responded to our advertise-
ments and met the clinical criteria tended to be minori-
ties. Specifically, the participants included: 57% African-
American, 23% Mexican American, 17% Caucasian, and
4% other.
Participants enrolled into the study met the criteria set
by the National Cholesterol Education Program (NCEP)
Adult Treatment Panel (ATP) Panel III for metabolic
syndrome defined as meeting at least three out of the
five following parameters: 1) waist circumference for
men > 40 in, for women > 35 in; 2) triglycerides > 150
mg/dl; 3) systolic blood pressure > 130 mm Hg or dia-
stolic blood pressure > 85 mm Hg; 4) fasting blood glu-
cose > 100 mg/dl; 5) HDL-cholesterol < 40 mg/dl for
men and < 50 mg/dl for females. Body mass indices
(BMIs) of the eligible participants could range from 30-
50 kg/m
2.
Participants were excluded from the study for the fol-
lowing reasons: use of anxiolytics or antidepressive med-
ication, hormone replacement therapy, reported alcohol
consumption in excess of 1 fluid ounce/day, diabetes
controlled with insulin, hyper- or hypothyrodism,
inflammatory disorders, treatment with corticosteroids
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other NSAIDs, or a history of a major cardiovascular
event. The following clinical parameters were exclusion-
ary: abnormal complete blood cell count defined as low/
high WBCs (less than 4.0 K/mm
3 or greater than 11.0
K/mm
3), hemoglobin (less than 11.5 or greater than
17.0 g/dL), platelets (less than 130 K/mm
3 or greater
than 450 K/mm
3), or a Beck Depression Inventory®
(BDI) scale score of 21 or above (Pearson Education,
Inc., San Antonio, Texas). With the exception of basic
multivitamin/mineral supplements, subjects were
instructed to refrain from using dietary supplements,
including herbs and omega-3 fatty acids during the
study period. Participants were instructed to refrain
from using nonsteroidal and anti-inflammatory medica-
tions for the week prior to a clinic visit. All subjects
provided written informed consent at the time of
screening, and the Institutional Review Board at Baylor
College of Medicine approved this study.
Study Design
Eligible subjects were randomized into one of three
groups: (1) 8 fluid ounces of low sodium vegetable
juice/day; (2) 16 fluid ounces of low sodium vegetable
juice/day; or (3) no vegetable juice/day, for a 12-week
period. Clinic visits were at baseline (week 0), week 6
and week 12 of the study. Subjects were instructed to
follow a low carotenoid diet for the week prior to the
baseline visit and a low flavonoid diet 24 hours prior to
all visits. Previous studies suggest that these dietary phy-
tochemicals can have a positive impact on vascular
function [26,27]. Three day diet records were collected
prior to the low carotenoid washout diet at baseline and
prior to the 24 hour low flavonoid diet at the 6 and 12
week visits.
All participants were asked to follow a calorie-con-
trolled DASH diet plan. Men were asked to follow an
1800 kcal diet and women a 1600 kcal diet. DASH is an
eating pattern recommended by the 2005 Department of
Health and Human Services Dietary Guidelines for
Americans as a model of healthy eating for the majority
of individuals in the population [28]. The DASH diet
emphasizes vegetables, fruits, whole grains, lean meats
and low fat dairy foods, and is rich in magnesium,
potassium, calcium and fiber [29]. At the baseline visit
following randomization to one of three groups, all par-
ticipants spent about 45 minutes with a dietitian learn-
ing the basics of the DASH diet. Dietitians emphasized
the following points of the nutrition education material
to participants:
1. Key aspects of the DASH eating plan placing
emphasis on vegetables and fruits.
2. Appropriate serving sizes of foods.
3. Realistic personal goals and meal plans.
4. Tips to make healthy eating easier.
5. Checklist to track their individual progress
towards meeting the DASH goals.
A notebook containing relevant DASH nutrition edu-
cation material was provided to participants. At the 6
week visit, a brief follow-up session was again conducted
with dietitians who asked about progress in following
the diet.
Participants randomly assigned to the beverage groups
were supplied with the low sodium vegetable juice for
each 6 week period. The juice was packaged in 46-
ounce bottles with a plain black and white label. The
same manufacturing lot was used for all subjects for the
12-week study period. A clear plastic glass with an 8
fluid ounce marker was provided for ease of juice mea-
surement. Eight fluid ounces of the low sodium vegeta-
ble juice (V8®; Campbell Soup Company, Camden NJ)
provided 50 calories, 0 g of total fat and cholesterol, 140
mg of sodium, 820 mg of potassium, 2 g of protein, 20
mg lycopene, and 10 g of total carbohydrate of which 2
g were dietary fiber. The juice provided 40% of the
Daily Value of Vitamin A from naturally occurring beta-
carotene in the vegetables (1000 IUs = 300 micrograms
RAEs (Retinol Activity Equivalents)), 120% of Vitamin
C, and 2% of calcium and iron.
Data Collection and Measures
General health, medication use and lifestyle characteris-
tics were assessed at baseline. At weeks 6 and 12, sub-
jects who consumed 8 or 16 fluid ounces of juice/day
completed an 8-item Beverage Consumption Question-
naire that included questions about the perceived taste
and health benefits of the beverage. Daily beverage con-
sumption was reported on checklists to measure adher-
ence to their allotted juice group protocol. Similar to
the literature, subjects were deemed highly adherent to
the protocol if they consumed their allotted amount of
juice at least 85% of the study days (72 of the 84 days of
the trial) [30,31]. Three-day food records were collected
from 2 weekdays and 1 weekend day before study visits
at baseline, week 6 and week 12. The food records were
reviewed by a registered dietitian when they were sub-
mitted and then were sent to the University of Califor-
nia, Davis where a registered dietitian supervised
duplicate data entry and analysis using Food Processor
software (Version 10.2.0, ESHA research, Inc., Salem,
OR). Vegetable servings were quantified according to
MyPyramid cup servings [32].
Clinical measurements included blood pressure,
weight, height, and waist circumference. Blood pressure
measurements were the average of 2 measurements and
were taken using an automated system (Dinamap Pro
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seated for 5 minutes. For weight and height measure-
ments, subjects were fully dressed, with the exception
that their shoes were removed. Height was recorded on
their first visit using a wall-mounted stadiometer (Accu-
stat Genentech, San Francisco, CA). Weight was
recorded every visit using an electronic scale (Tanita,
BWB–800. Tokyo, Japan.). Body mass index (kg/m
2) was
calculated as weight (kg) divided by height squared (m
2).
At the screening visit, blood samples were drawn for
the comprehensive metabolic panel (chemistry, lipid,
fasting blood glucose, liver function and complete blood
count) and analyzed at the Clinical Pathology Labora-
tory in Austin, TX. At baseline, 6 and 12 weeks, blood
samples for lipids, high sensitivity C-reactive protein
(hsCRP), glycated hemoglobin (HgA1c) and insulin were
analyzed at the Atherosclerosis Clinical Research
Laboratory, a core laboratory in the Department of
Medicine at Baylor College of Medicine. Plasma was col-
lected for the measurement of adhesion markers, leptin,
and for plasma indicators of oxidant defense (total reac-
tive antioxidant potential (TRAP)) and oxidative damage
(thiobarbituric acid reactive substances (TBARS)). TRAP
and TBARS were analyzed as previously described [33].
Leptin, and vascular adhesion markers (soluble-Inter-
cellular Adhesion Molecule-1, soluble-Vascular Cell
Adhesion Molecule-1, soluble P-Selectin, soluble E-
Selectin), and soluble CD40 ligand were measured using
a commercially available enzyme-linked immunosorbent
assay (ELISA) kits (leptin, adhesion markers: R&D Sys-
tems, Minneapolis, MN, sCD40L: Bender MedSystems,
Burlingame, CA) according to the manufacturer’s
instructions.
Statistical Approach
Descriptive data (means, standard deviations) are pro-
vided for study outcomes stratified by the three study
conditions. For weight change, descriptive data also is
presented after applying imputational methods
(described below) for modeling missing data.
Changes in Body Weight
Three different unadjusted statistical models were cre-
ated to examine the impact of the three study condi-
tions on body weight. The first model examined weight
loss among completers of the three treatment condi-
tions. Next, two models which imputed treatment out-
come data for participants who dropped out of the
study were developed. The first imputational model was
based on the Last Observation Carried Forward (LOCF)
[34,35] method. The second imputation model used a
conservative Intention-to-Treat (ITT) method where
missing values are imputed based on average weight
gain after dropout of 0.30 kg/month (or 0.075 kg/week)
after study withdrawal, an approach that has been used
successfully in other large clinical trials [35,36] and is
even more conservative because it assumes that weight
regain can exceed baseline weight. For all three models,
General Linear Models for repeated measures were
developed where the between-subjects factor was group
assignment and the within-subjects factor was body
weight at baseline, 6 weeks,a n d1 2w e e k s .D a t aw e r e
examined based on a comparison of the results from the
three methods for modeling missing data. A multivariate
approach was used to test a group by time interaction in
each model based on the Wilks Lambda test of signifi-
cance. The multivariate test was conducted on differ-
ence scores, and therefore the assumptions underlying
the multivariate test concern these difference scores.
Difference scores (change from baseline) for weight out-
comes are presented to aid interpretability. LSD and the
more conservative Tukey HSD post-hoc comparisons
were used for any statistically significant unadjusted
model.
Changes in Leptin, Adhesion Markers, CD40L, Blood
Pressure, and Food Record Data
General linear models with repeated measures were
used to examine changes in leptin, adhesion markers,
blood pressure, and food diary data for the three study
conditions. All models are based on participants who
completed the study given that imputational approaches
for small samples are not well developed for these fac-
tors. Tukey post-hoc comparisons were used for any sta-
tistically significant unadjusted model.
Adjusted Aggregate Models
Given the attrition observed in the study, the resultant
reduction in statistical power, and the fact that no dif-
ferences were found between the 8 fluid ounce low
sodium vegetable juice and 16 fluid ounce juice condi-
tions on any outcome, the 8 and 16 fluid ounce juice
groups were aggregated into a single group and the
aggregated condition was compared to the group that
did not consume the juice (control group). Thus, aggre-
gate models were developed to compare any low sodium
vegetable juice consumption to none. In addition, gen-
der, education, and age were included as covariates in
the adjusted models. These covariates were selected
because of the relatively large differences in their distri-
bution by group status even though the differences were
not statistically significant, as well they were used
because have been previously demonstrated to be
related to weight loss outcomes [37-39].
Medication use was also examined to assess whether
inclusion of a measure of medication use (i.e., number
of medications used) enhanced the precision of out-
comes models. This was implemented because outcome
variables might be affected by prescription and OTC
medication use, i.e., weight, leptin, systolic and diastolic
blood pressure, and all lipid fractions. Any listed
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tion (i.e., any nutritional supplement or vitamin). How-
ever, clear distinctions between prescription and over
the counter (OTC) medications was not possible
because some OTC drugs were prescribed (e.g., aspirin)
and some participants did not list an actual medication,
but instead a class of medications (e.g., “blood pressure
medicine” or “allergy pills”). Thus, all OTC and pre-
scription medication were grouped and counted as the
total number of medications for each participant. The
simplified models with juice consumption aggregated
showed that that the addition of frequency of medica-
tion use did not substantially improve already significant
models and did not change models that were previously
not statistically significant.
Results
A total of 81 individuals participated in the study (27 in
each study condition) (Figure 1). Baseline characteristics
of the participants were similar among groups (Table 1).
Overall retention was 74% and attrition was similar
across groups. None of the baseline characteristics or
treatment group status were associated with dropping
out of the study.
We observed that 100% of subjects in the 8 fluid
ounce/day group had high rates of adherence (i.e., bev-
erage consumption on >85% of days in the study) over
the 12 week trial, whereas only 53% of subjects in the
16 fluid ounce/day group had the same level of
adherence.
Weight Loss
All three models (i.e., completers, LOCF, and conserva-
tive ITT) demonstrated that participants in the two
vegetable juice groups lost more weight, on average,
than the group that did not drink the juice. However,
there were no statistically significant group differences
in weight loss over time (i.e., group by time interaction)
(Table 2). When using adjusted, aggregated models,
(vegetable juice vs. no vegetable juice) the group by time
interaction tests for weight were statistically significant
for completers (F = 4.3, p = 0.02; data not shown) and
the LOCF and ITT models (F = 3.8, p = 0.03 for both;
data not shown), indicating that participants who con-
sumed one or more servings of vegetable juice experi-
enced significantly more weight loss than those who did
not consume the juice.
Leptin
Both unadjusted and adjusted statistical models were
created to examine the impact of the three study condi-
tions on leptin. Table 3 presents changes in leptin by
group status over the 12-week trial. The unadjusted
model for leptin was statistically significant between the
groups over the 12 week study period (F = 3.4, p =
0.01). Similarly, in the adjusted model of aggregated
vegetable juice groups, there was a significant group by
time interaction for leptin (Table 3; F = 3.4, p = 0.04)
that paralleled weight loss. Additionally, post-hoc paired
t-tests comparing baseline levels to both 6- and 12-week
only showed significant changes in those consuming 8
fluid ounces of vegetable juice (respectively, t = 2.578,
p = 0.02; t = 3.767, p = 0.002).
Blood Pressure and Plasma Measurements
Systolic or diastolic blood pressure was not statistically
significantly changed (data not presented) between
groups over the 12 week study period. No significant
differences were observed in the markers of oxidant
defense or oxidative stress (TRAP and TBARS respec-
tively) that were assessed in the study (data not pre-
sented). No significant differences were observed in any
of the vascular adhesion markers, hsCRP, HgA1c, and
sCD40L (data not shown).
Food Records Data
Table 4 presents food record data of selected nutrients
for completers stratified by treatment condition. Table 5
shows vegetables intake by cups, in accordance with the
MyPyramid definition [32], and by study treatment
group, first with counting the vegetable juice followed
by without vegetable juice as part of the sum of vegeta-
ble intake. Unadjusted General Linear Models examin-
ing group by time interactions among completers for
food records were first computed. As shown in Tables 4
and 5, groups consuming vegetable juice increased their
intake of vitamin C (F = 6.5, p < 0.001), potassium (F =
3.9, p < 0.002), and vegetables (F = 4.3, p = 0.003) over
time compared to those who did not consume juice.
Vitamin C post-hoc analyses revealed that intakes
were significantly higher in the 16 fluid ounce/day
g r o u pt h a ni nt h e8f l u i do u n c e s / d a yg r o u p( p=0 . 0 0 2
and 0.005 for LSD and Tukey HSD, respectively). Vita-
min C intakes were also higher in the 16 fluid ounce/
day group versus the group not consuming any juice
(p < 0.001 for both LSD and Tukey HSD). Using the
LSD test, those who drank 8 fluid ounces/day of vegeta-
ble juice reported higher vitamin C intakes than those
who did not drink the juice (p = 0.03). However, the dif-
ference between the 8 fluid ounces/day vegetable juice
and no vegetable juice group was not significant using
the Tukey HSD (p = 0.07).
With respect to potassium, post-hoc analyses showed
those who consumed 16 fluid ounces/day vegetable juice
reported higher intake relative to the 8 fluid ounces/day
group (p = 0.001 and 0.004 for LSD and Tukey HSD,
respectively). Those who consumed no vegetable juice
had significantly lower intakes of potassium than those
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LSD and Tukey HSD). The difference between the 8 fluid
ounces/day vegetable juice and the no juice group
was not statistically significant for either post-hoc test
(p = 0.06 and 0.13 for LSD and Tukey HSD, respectively).
Post-hoc analyses of vegetable intake using the MyPyr-
amid vegetable definition illustrated those who did not
incorporate the vegetable juice into their diet reported
significantly less vegetable intake than those who con-
sumed 8 fluid ounces/day of vegetable juice (p = 0.002
and < 0.001 for LSD and Tukey HSD, respectively); the
difference between the 8 fluid ounce/day and 16 fluid
ounce/day juice groups was non-significant (p = 0.40
and 0.68 for LSD and Tukey HSD, respectively).
Given study attrition, the adjusted and aggregated
models were computed. These data showed significant
16 fluid ounces vegetable 
juice
Allocated to intervention  
n= 27 
Completed allocated 
intervention 
n = 22 
(81%) 
Did not complete allocated 
intervention  
n = 5 
Reasons: loss to follow-up 
(n=3); did not like juice 
(n=1); moved (n= 1) 
8 fluid ounces vegetable 
juice
Allocated to intervention  
n= 27 
Completed allocated 
intervention 
n = 18 
(67%) 
Did not complete allocated 
intervention n = 9 
Reasons: loss to follow-up 
(n=4); personal reasons 
(n=4); moved (n= 1) 
Assessed for eligibility 
N = 1094 telephone screens 
No vegetable juice 
Allocated to control  
n= 27 
Completed allocated 
intervention 
n = 20 
(74%) 
Did not complete allocated 
intervention n = 7 
Reasons: loss to follow-up 
(n=2); personal reasons 
(n=4); clinical measure 
(n= 1) 
Randomized
Enrollment  
N = 81 
Excluded n = 1013 
Did not meet inclusion criteria as 
determined by telephone contact  
 n = 841 (77%) 
Did not meet inclusion criteria after 
screening visit  
n =129 (clinical and laboratory 
exclusions) (51%)
Refused to participate  
n = 24 (too much time, changed mind, 
job schedule) (9%)
Other reasons n = 19 (BMI status 
changed, exclusionary medication) 
(8%)
Figure 1 Enrollment and Randomization.
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consuming juice compared to the control group for
carbohydrates (F = 3.3, p = 0.05), total sugars (F = 3.3,
p = 0.05; data not shown), vitamin C (F = 4.6, p =
0.02), and potassium (F = 3.9, p = 0.03). Those con-
suming vegetable juice significantly reduced their car-
bohydrate and sugar intake over time compared to
those not consuming juice. Additionally, those drinking
juice significantly increased their potassium intake over
time compared to those not drinking it. Participants
consuming vegetable juice experienced large increases
over time in vegetable intake relative to the no juice
group (see Table 5) using MyPyramid (F = 3.6, p =
0.04) vegetable categorization method. However, when
vegetable juice intake is excluded from being counted
in the dietary intake, there were no significant changes
Table 2 Weight Loss (kg; M, SD) Over Time by Group Status for Completers, LOCF, and Conservative ITT Models
Treatment Group
Weight Loss Marker No Vegetable Juice 8 fluid ounces Vegetable Juice 16 fluid ounces Vegetable Juice
6 Weeks 12 Weeks 6 Weeks 12 Weeks 6 Weeks 12 Weeks
Completers (kg) N 19 20 18 18 23 22
Mean 0.26 -0.55 -1.36 -2.25 -0.97 -1.35
SD 1.11 2.77 1.83 2.72 2.13 2.72
LOCF (kg) N 27 27 27 27 27 27
Mean 0.19 -0.41 -0.90 -1.55 -0.82 -1.20
SD 0.93 2.38 1.62 2.43 1.99 2.52
ITT (kg) N 27 27 27 27 27 27
Mean 0.32 -0.17 -0.75 -1.20 -0.76 -0.93
SD 0.93 2.45 1.72 2.67 2.02 2.60
LOCF = Last Observation Carried Forward
ITT = Intent to Treat
Table 1 Participant Characteristics by Group Assignment (Mean or %, SD)
Group Assignment
Demographic and Clinical Characteristics No Vegetable
Juice
8 fluid ounces Vegetable
Juice
Per Day
16 fluid ounces
Vegetable Juice
Per Day
All
Participants
Female* (%) 74.1 85.2 59.3 72.8
Ethnicity (%)
-White 19.2 15.4 14.8 16.5
-African-American 50.0 57.7 63.0 57.0
-Mexican-American 30.8 23.1 14.8 22.8
-Other 0.0 3.8 7.4 3.7
Education: High School or Less (%) 56.0 62.5 58.3 58.9
Current Smoker (%) 14.8 14.8 11.5 13.3
Age (Years) 50.1 (5.1) 51.2 (7.4) 48.0 (7.7) 49.8 (6.9)
Baseline Weight (kg) 104.2 (18.1) 100.2 (17.6) 112.4 (18.1) 105.6 (18.4
Baseline BMI 37.8 (4.6) 37.3 (5.3) 38.3 (4.9) 37.8 (4.9)
Baseline Waist Circumference (cm) 115.3 (13.3) 112.9 (10.5) 119.1 (15.2) 115.8 (13.3)
Baseline Systolic Blood Pressure (mmHg) 132.8 (20.9) 134.5 (20.6) 124.4 (15.3) 130.6 (19.4)
Baseline Diastolic Blood Pressure (mmHg) 84.8 (11.8) 83.8 (11.5) 80.5 (9.9) 83.0 (11.1)
Baseline Medication Use (#) 1.7 (2.0) 1.8 (2.2) 1.0 (1.6) 1.5 (2.0)
Baseline Metabolic Syndrome Criteria (% with criteria)
Waist Circumference
(≥ 88 cm for women or ≥ 102 cm for men; %)
100.0 100.0 100.0 100.0
Blood Pressure
(Systolic ≥ 130 mmHg or Diastolic ≥ 85 mmHg; %)
63.0 51.9 40.7 51.9
Triglycerides (≥ 150 mg/dl; %) 37.0 25.9 23.1 28.9
HDL (Men <40 mg/dl or Women <50 mg/dl; %) 96.0 80.8 87.5 88.0
Blood Glucose (≥ 100 mg/dl; %) 100.0 96.3 100.0 98.7
*c
2 = 4.6, p = 0.10
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regard to usual vegetable intake.
Metabolic Syndrome
Based on group assignment, there was a significant dif-
ference in the percent of subjects who met the meta-
bolic syndrome criterion of elevated triglycerides at the
end of the 12 week study, (Chi-square = 7.9; p = 0.02)
with 40.0% still meeting the criterion in the no juice
control group, while 5.6% and 13.6% met the criterion
in the 8 fluid ounce/day and 16 fluid ounce/day juice
groups respectively. A follow-up logistic model with the
juice groups aggregated (comparing any vegetable juice
consumption to none) and adjusting for age, education,
and gender was developed to predict meeting the ele-
vated triglyceride criterion at 12 weeks. This model
demonstrated that those drinking the vegetable juice
(10.0%) were less likely (OR = 0.91; p = 0.01) to meet
the triglyceride criterion for metabolic syndrome than
those not receiving the juice (40.0%). The overall model
was statistically significant (Chi-square = 19.5; p =
0.003). There were no significant differences among
groups with any of the other metabolic syndrome
criteria.
Discussion
Diets rich in vegetables and fruits have been shown to
help individuals reach and achieve a healthy weight [5]
and improve cardiovascular disease risk [7,40]. This
positive result has been attributed to the fact that vege-
tables and fruit are typically low in calories and have
been shown to increase satiation [6,41]. However, adopt-
ing and maintaining a healthy lifestyle that includes a
diet rich in vegetables, fruits, lean meats and low fat
dairy products, is problematic for many individuals [8].
The current study examined whether including an easily
accessible, portable vegetable-based beverage as part of
a calorie-controlled DASH diet could increase vegetable
intake and improve clinical characteristics of the meta-
bolic syndrome in a group of individuals with a mean
age of 49.8 years, predominately female (73%), with 84%
self-identified as African American, Mexican American
or other minority. During the 12 week study, partici-
pants received two individual counseling sessions with
registered dietitians (at baseline and 6 weeks). Although
everyone was counseled on a calorie-controlled DASH
diet only those who were instructed to also incorporate
8 and 16 fluid ounces of vegetable juice per day signifi-
cantly increased their vegetable consumption and signifi-
cantly reduced their carbohydrate intake. Regardless of
whether vegetable servings included or excluded the
“starchy vegetables” (such as those defined by the Dia-
betic Vegetable Exchanges [42]), subjects consumed sig-
nificantly more vegetables in the juice treatment groups.
This dietary practice translated to a significant amount
of weight loss in the vegetable juice groups compared to
those who did not incorporate the vegetable juice into
the DASH diet. The amount of weight lost was modest,
approximately 0.33 lb per week. But, this positive,
“small-step” change is thought to be successful [43] and
in our intervention resulted in a significantly greater
weight loss over the 12 weeks in the group that incorpo-
rated vegetable juice into the DASH diet compared to
the group that did not drink the juice.
Individuals with metabolic syndrome are at higher risk
for both diabetes and atherosclerotic cardiovascular dis-
ease. Weight reduction is known to improve risk factors
associated with metabolic syndrome [44,45]. In the cur-
rent study, after 12 weeks of vegetable juice consump-
tion, the modest reduction in weight (<5% for most
subjects), translated to a lower percentage of subjects
that met the metabolic syndrome criteria for high trigly-
cerides (i.e. >150 mg/dl). No significant changes were
observed in any of the other measured metabolic or car-
diovascular risk factors. However, we did observe a sig-
nificant decrease in plasma leptin. Leptin is synthesized
and secreted from adipocytes and is highly correlated
with energy storage in adipose tissue [46,47]. Analogous
to our results, the observation that changes in leptin
and triglycerides parallel weight loss, regardless of
mechanism to reduce weight, has been observed by
other investigators [48,49].
It is important to note that the DASH diet instructions
emphasized including vegetables of all forms in their
daily diets, but only those groups provided with the sim-
ple intervention of adding vegetable juice significantly
increasing vegetable intake. According to subjects’
responses on the Beverage Consumption questionnaires,
Table 3 Means (SD) for Leptin
Leptin* (pg/ml) Baseline 6-weeks 12-weeks
No Vegetable Juice 2.93 × 10
4
(1.99 × 10
4)
3.07 × 10
4
(2.30 × 10
4)
3.57 × 10
4
(3.09 × 10
4)
8 fluid ounces Vegetable Juice 4.30 × 10
4
(1.81 × 10
4)
3.51 × 10
4
(1.33 × 10
4)
3.16 × 10
4
(1.12 × 10
4)
16 fluid ounces Vegetable Juice 3.87 × 10
4
(2.99 × 10
4)
4.47 × 10
4
(2.85 × 10
4)
4.27 × 10
4
(2.97 × 10
4)
*p-value = 0.01 for overall repeated measures model interaction among treatment and change from baseline to 12 weeks.
Shenoy et al. Nutrition Journal 2010, 9:8
http://www.nutritionj.com/content/9/1/8
Page 8 of 12the juice was an acceptable addition to their diets. Apart
from the vegetable juice, our subjects would not have
met vegetable recommendations. Many different popula-
tion groups do not meet current vegetable recommenda-
tions [50-52]. Inadequate vegetable intake is a widespread
issue [53]. Although campaigns promoting vegetables and
fruits, such as the 5-A-Day program, have been
publicized in the media and the public recognizes them
[54], there is disconnect between the recommendations
and typical consumption [6,50,51,55]. In agreement with
the above, in the current study, despite our DASH diet
education, including an emphasis on vegetable intake, we
observed no increases in dietary vegetables, apart from
the added vegetable juice over time.
Table 4 Food Record Data: Completers Juice Data Included
Nutrient Measurement Point
Mean (SD) Baseline 6 Weeks 12 Weeks
Total Calories
No Vegetable Juice 1898.5 (599.9) 1986.7 (687.6) 1865.9 (667.3)
8 fluid ounces Vegetable Juice 2015.9 (931.9) 1672.6 (1146.7) 1654.7 (571.6)
16 fluid ounces Vegetable Juice 2184.0 (703.6) 2030.1 (984.4) 1676.7 (429.7)
Percent of Calories from Fat
No Vegetable Juice 37.5 (7.4) 31.7 (14.1) 33.8 (7.5)
8 fluid ounces Vegetable Juice 39.3 (7.8) 33.9 (16.2) 29.7 (9.5)
16 fluid ounces Vegetable Juice 35.8 (7.4) 27.9 (13.4) 32.4 (9.7)
Protein Intake (g)
No Vegetable Juice 84.2 (29.1) 89.8 (36.4) 78.2 (30.3)
8 fluid ounces Vegetable Juice 79.6 (27.2) 74.3 (35.1) 63.5 (16.1)
16 fluid ounces Vegetable Juice 95.6 (36.6) 91.2 (37.1) 76.4 (19.2)
Carbohydrate Intake (g)
No Vegetable Juice 209.9 (60.0) 244.0 (100.7) 234.3 (103.3)
8 fluid ounces Vegetable Juice 224.2 (106.4) 195.2 (64.5) 220.3 (73.5)
16 fluid ounces Vegetable Juice 256.2 (96.1) 219.3 (80.5) 205.4 (75.7)
Fat Intake (g)
No Vegetable Juice 80.8 (37.4) 68.8 (37.0) 70.3 (30.5)
8 fluid ounces Vegetable Juice 90.6 (55.3) 54.5 (31.8) 58.3 (34.0)
16 fluid ounces Vegetable Juice 86.3 (32.8) 56.6 (24.2) 61.8 (29.0)
Vitamin A Carotenoid (RE)
No Vegetable Juice 157.0 (191.4) 541.4 (826.6) 424.7 (544.1)
8 fluid ounces Vegetable Juice 514.6 (557.2) 601.3 (788.6) 491.6 (628.0)
16 fluid ounces Vegetable Juice 218.0 (264.7) 403.8 (479.1) 485.5 (528.1)
Vitamin C* (mg)
No Vegetable Juice 65.9(77.9) 69.3(45.6) 97.8(76.5)
8 fluid ounces Vegetable Juice 88.8(64.5) 132.5(30.1) 146.1(50.2)
16 fluid ounces Vegetable Juice 63.5(44.1) 236.8(108.4) 240.7(91.5)
Sodium (mg)
No Vegetable Juice 3589.7 (1372.2) 3386.2 (1213.2) 3775.2 (1572.8)
8 fluid ounces Vegetable Juice 3274.5 (1492.2) 2699.2 (1273.4) 2707.6 (1133.3)
16 fluid ounces Vegetable Juice 4283.0 (3843.3) 2697.6 (959.2) 2995.7 (1100.5)
Potassium* (mg)
No Vegetable Juice 1784.3 (777.4) 1954.8 (892.7) 1695.0 (675.5)
8 fluid ounces Vegetable Juice 2004.1 (824.9) 2391.3 (645.8) 2496.0 (776.2)
16 fluid ounces Vegetable Juice 2057.1 (1029.0) 3170.0 (868.2) 3341.4 (822.8)
Fiber (g)
No Vegetable Juice 17.5(8.1) 18.0(8.4) 19.3(9.4)
8 fluid ounces Vegetable Juice 20.6(12.2) 19.2(8.4) 16.9(5.3)
16 fluid ounces Vegetable Juice 16.8(8.6) 20.5(10.3) 18.6(7.3)
*p-value < 0.05 for overall repeated measures model interaction among treatment and change from baseline to 12 weeks.
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significant dietary improvements. McGee et al. studied a
population with similar education to the present study,
with approximately half of the participants with a high
school education or less, and found that barriers to
change towards a more healthful diet included lack of
knowledge and skills [9]. Despite the fact that we pro-
vided our subjects with DASH diet knowledge and food
preparation tips, our participants still did not meet their
vegetable recommendations unless a vegetable juice bev-
erage was provided to them. Although a serious disease
may motivate changes in dietary behavior, our subjects
had cardiovascular risk factors, rather than a major car-
diovascular event, which may have reduced their incen-
tive to follow DASH diet guidelines [9]. For example,
Campbell et al. found that in a predominantly female
population, consisting of a high percentage of minori-
ties, it was possible to increase knowledge of infant feed-
ing through education but that knowledge alone did not
elicit change in dietary behaviors [56]. Dietary interven-
tions and education targeting minorities is especially dif-
ficult [57,58]. However, our study showed beneficial
dietary changes in minorities. Participants provided a
vegetable beverage greatly enhanced their vegetable con-
sumption, something the DASH counseling and materi-
als alone, were unable to achieve. Consistent with the
current study, Weerts et al. [59] reported that African
American women, given nutritional and behavioral edu-
cation, were more likely to increase their consumption
of vegetables and consequently lose weight when they
were provided with gift cards that were explicitly for
vegetables and fruits.
While studies have observed blood pressure reduc-
tions in trials incorporating tomato based products
[21,22], we did not. These studies used tomato-based
extracts, rather than a tomato-based juice. In addition to
a lack of effect on blood pressure, vegetable juice
consumption also did not correlate to an improvement
in oxidative stress parameters, although a significant
increase in vitamin C intake was observed in the vegeta-
ble juice groups. We note that other markers of antioxi-
dant and oxidative stress may have yielded different
results [60].
Limitations of the current study design include its
short duration of 12 weeks. A longer study could pro-
vide data on weight loss maintenance, a key factor for
weight control and health. In addition, since attrition
was slightly higher than anticipated, even though it was
not significantly different among groups, it became
necessary to aggregate the groups consuming the vege-
table juice for statistical power. While examination of
the variables using the LOCF and ITT models did not
reach statistical significance, they do show the same
basic trends as the aggregated models. When looking at
the more conservative models combined with the aggre-
gated model, we acknowledge that our findings are pre-
liminary and more research is needed. Another
limitation to our study was the relatively modest-to-low
rate of adherence among the 16 fluid ounces/day group.
There were no significant differences in the adjusted
models for weight loss among all three groups, however,
on average, those who consumed 16 fluid ounces/day
lost less weight than those who consumed 8 fluid
ounces/day. It is difficult to know why the 16 fluid
ounces/day group may not have been as effective as the
8 fluid ounces/day group in terms of weight loss. One
possibility is the relatively low adherence to the inter-
vention protocol in those assigned to consume a greater
volume of juice. This finding indicates that it may be
difficult, in a clinical or public health setting to recom-
mend drinking 16 fluid ounces/day of vegetable juice.
Conclusion
In conclusion our study demonstrates that the incor-
poration of vegetable juice is a simple and effective way
to help meet vegetable recommendations and improve
Vitamin C and potassium intake. Data from this study
also suggest the potential of using a low sodium vegeta-
ble juice in conjunction with a calorie restricted diet to
aid in weight loss in overweight individuals with meta-
bolic syndrome.
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